Skip to content
Sectors How it works Pricing Client stories

Insights

Companies Live signals Events Markets Trends Company lists
Log in
Platform Signal Tracker API Radar Book a 7-day Readout
Acomhal Research, Inc. logo — Providing novel and effective therapeutic approaches to prev...

Acomhal Research, Inc.

Providing novel and effective therapeutic approaches to prevent tumor recurrence and metastasis

Founded 2016 United States Roanoke, United States 2 employees Grant Total: $305.00K Biotechnology, Health Care +1

General Information

Company Name Acomhal Research, Inc.
Founded Year 2016
Location United States Roanoke, United States
Employees 2
Industries Biotechnology, Health Care, Life Sciences
Funding Stage Grant
Social

BounceWatch is an independent company data service, not affiliated with Acomhal Research, Inc.. To contact Acomhal Research, Inc., visit acomhalresearch.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Acomhal Research, Inc. compare?

A PDF of Acomhal Research, Inc. and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Acomhal Research, Inc. soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Acomhal Research, Inc.

Acomhal Research, Inc. is a biotechnology company founded in 2017, headquartered in the United States. The company's slogan, "Providing novel and effective therapeutic approaches to prevent tumor recurrence and metastasis," encapsulates its core mission. Acomhal Research is dedicated to developing and offering innovative therapeutic solutions to combat tumor relapse and metastatic growth. Recently, the company secured a $305.00K grant investment on 04 January 2022, with backing from notable investors including VIPC’s Virginia Venture Partners, Virginia Tech Innovation Fund, and CommonWealth Angels. This recent investment demonstrates growing support and confidence in Acomhal Research's groundbreaking work within the biotechnology and healthcare sectors. With a focus on addressing critical medical challenges, such as tumor recurrence and metastasis, the company is poised to make a significant impact in the field of cancer therapeutics. This financial backing will likely propel the company's research, development, and market expansion efforts, underscoring its potential for future growth and success. Acomhal Research's ability to attract funding from reputable investors underscores the industry's recognition of the company's innovative approach and the potential significance of its work. This recent investment not only provides crucial financial resources but also validates the company's efforts to revolutionize therapeutic approaches in the fight against cancer. As the company continues to advance its research and development initiatives, it is positioned to emerge as a key player in shaping the future of cancer treatment and patient care.

Business keywords: oncology, cancer therapy, tumor recurrence prevention, metastasis prevention, therapeutic approaches, biomedical research, clinical trials, innovative treatments

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Grant $305.00K 3
VIPC’s Virginia Venture Partners Virginia Tech Innovation Fund CommonWealth Angels
VIPC’s Virginia Venture Partners, Virginia Tech Innovation Fund +1
04 Jan 2022

Acomhal Research, Inc. Alternatives & Competitors

View All Alternatives
Acomhal Research, Inc. vs
Vuja De Sciences
Vuja De Sciences

Vuja De is dedicated to developing cancer metastasis treatments that prevent cancer progression and...

Venture round
7 employees
Biotechnology, Health Care
Acomhal Research, Inc. vs
HiberCell
HiberCell United States

Developing Novel Therapeutics to Prevent Cancer Relapse and Metastasis

25 employees
Biotechnology, Health Care
Acomhal Research, Inc. vs
EV Therapeutics
EV Therapeutics United States

Immunotherapy EVolved.

2 employees
Biotechnology, Health Care
View all alternatives

FAQ About Acomhal Research, Inc.

Providing novel and effective therapeutic approaches to prevent tumor recurrence and metastasis
Acomhal Research, Inc. was founded in 2016.
Acomhal Research, Inc. is headquartered in Roanoke, United States.
Acomhal Research, Inc. operates in Biotechnology, Health Care and Life Sciences. Its work centres on oncology, cancer therapy, tumor recurrence prevention and metastasis prevention.
Acomhal Research, Inc. has approximately 2 employees.
Acomhal Research, Inc. has completed 1 funding round, raising a total of $305.00K. The latest funding stage is Grant.
Top alternatives and competitors to Acomhal Research, Inc. include Vuja De Sciences, HiberCell, EV Therapeutics, IV Diagnostics, Soricimed Biopharma Inc.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Acomhal Research, Inc. and Vuja De Sciences are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Acomhal Research, Inc., https://bouncewatch.com/company/acomhal-research-inc, updated 9 November 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout